BEGHE', Bianca
 Distribuzione geografica
Continente #
NA - Nord America 18.627
AS - Asia 7.939
EU - Europa 7.482
SA - Sud America 1.133
AF - Africa 183
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 6
Totale 35.425
Nazione #
US - Stati Uniti d'America 18.406
SG - Singapore 2.463
GB - Regno Unito 2.358
IT - Italia 1.982
CN - Cina 1.977
HK - Hong Kong 1.047
BR - Brasile 861
VN - Vietnam 798
SE - Svezia 531
DE - Germania 514
FI - Finlandia 462
UA - Ucraina 353
BD - Bangladesh 336
RU - Federazione Russa 310
FR - Francia 308
KR - Corea 248
TR - Turchia 217
ID - Indonesia 208
IN - India 157
BG - Bulgaria 152
CA - Canada 97
AR - Argentina 92
NL - Olanda 82
MX - Messico 80
IQ - Iraq 70
ZA - Sudafrica 66
PK - Pakistan 61
CO - Colombia 57
ES - Italia 55
AU - Australia 50
JP - Giappone 45
IE - Irlanda 44
RO - Romania 43
AT - Austria 41
AE - Emirati Arabi Uniti 37
MY - Malesia 35
PL - Polonia 35
CL - Cile 30
LT - Lituania 30
VE - Venezuela 30
BE - Belgio 28
IR - Iran 27
CH - Svizzera 26
EC - Ecuador 26
SA - Arabia Saudita 22
PH - Filippine 20
TH - Thailandia 18
NP - Nepal 17
JO - Giordania 16
PY - Paraguay 16
RS - Serbia 16
KE - Kenya 15
UZ - Uzbekistan 15
PT - Portogallo 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
EG - Egitto 13
MA - Marocco 13
SY - Repubblica araba siriana 13
TN - Tunisia 13
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
IL - Israele 10
KZ - Kazakistan 10
UY - Uruguay 9
AZ - Azerbaigian 8
BF - Burkina Faso 8
ET - Etiopia 8
MD - Moldavia 8
NO - Norvegia 8
PE - Perù 8
SI - Slovenia 8
HU - Ungheria 7
OM - Oman 7
CR - Costa Rica 6
EE - Estonia 6
JM - Giamaica 6
LB - Libano 6
NG - Nigeria 6
AO - Angola 5
BH - Bahrain 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
BY - Bielorussia 4
LY - Libia 4
MN - Mongolia 4
PA - Panama 4
PR - Porto Rico 4
QA - Qatar 4
SN - Senegal 4
CG - Congo 3
Totale 35.371
Città #
Ashburn 1.694
Fairfield 1.600
Southend 1.573
Singapore 1.469
Santa Clara 1.450
Hong Kong 1.028
Woodbridge 979
Chandler 931
Houston 834
Hefei 674
Jacksonville 662
San Jose 644
Chicago 624
Seattle 570
Wilmington 563
Cambridge 513
Dearborn 504
Los Angeles 420
London 416
Ann Arbor 360
Beijing 349
Helsinki 337
Council Bluffs 333
Salt Lake City 283
New York 278
Modena 246
Nyköping 240
Ho Chi Minh City 232
Hanoi 224
Seoul 222
The Dalles 212
Milan 205
San Diego 190
Dallas 166
Princeton 161
Tampa 148
Sofia 146
Elk Grove Village 133
Rome 130
Eugene 116
Lauterbourg 113
Buffalo 103
Jakarta 94
São Paulo 94
Izmir 93
Moscow 83
Redwood City 75
Des Moines 72
Naples 71
Shanghai 67
Frankfurt am Main 66
Lancaster 65
Sterling 60
Boardman 54
Columbus 53
Phoenix 44
Da Nang 43
Miami 43
Orem 43
Nuremberg 38
Dublin 37
Atlanta 35
Bologna 35
Falls Church 35
Detroit 34
Tokyo 34
Kansas City 30
Toronto 30
Bogotá 29
Grafing 29
Munich 28
Verona 28
Mexico City 27
Redondo Beach 27
Ankara 26
Florence 26
Haiphong 26
Kent 26
Rio de Janeiro 26
Dulles 25
Norwalk 25
Baghdad 24
Belo Horizonte 24
Chennai 24
Johannesburg 23
Miano 23
San Francisco 23
Warsaw 23
Brooklyn 22
Montreal 21
Nanjing 21
Vienna 21
Bari 20
Palermo 20
Brussels 19
Buenos Aires 19
Amsterdam 18
Charlotte 18
Genoa 18
Jersey City 18
Totale 24.250
Nome #
The genetic basis of atopic asthma. 833
Asma bronchiale 662
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 486
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 484
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 390
Chronic respiratory abnormalities in the multi-morbid frail elderly 388
Acute severe asthma: management and treatment. 382
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 375
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 375
Airway inflammation in childhood asthma 369
Physiologic consequences of long term inflammation 351
Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. 348
Comparison of two methods of processing induced sputum: selected versus entire sputum. 342
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections 341
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis 336
La broncopneumopatia cronica ostruttiva nell'anziano 332
Update in Chronic Obstructive Pulmonary Disease 2005 331
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 331
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 325
Roflumilast:un nuovo farmaco per il trattamento della BPCO 324
Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). 323
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 322
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 319
Update in chronic obstructive pulmonary disease 2006 317
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate 317
Inhaled Corticosteroids in COPD: Pros and Cons. 316
Treatment of chronic obstructive pulmonary disease and its comorbidities 315
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 315
Complex chronic co-morbidities of COPD 313
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 313
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 312
Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. 309
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 306
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 303
Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. 301
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. 297
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 296
The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma 295
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 295
La genetica dell’asma bronchiale. 293
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 291
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 287
[Pathology of chronic obstructive pulmonary disease] 281
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients. 281
Role for CXCR6 and its Ligand CXCL16 in the Pathogenesis of T-cell Alveolitis in Sarcoidosis 278
Leukotriene B4 receptor locus gene characterisation and association studies in asthma 274
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma 272
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 271
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 271
Alveolar and bronchiolar inflammation in COPD 269
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes. 265
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 262
Eosinophilia in asthma: the easy way is not always the best 262
Significant chronic airway abnormalities in never-smoking HIV-infected patients 256
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 255
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 254
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 252
Basi strutturali della BPCO. 250
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 250
Polymorphisms in the interleukin-4 and interleukin-4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population 249
La NIV nel paziente con insufficienza respiratoria cronica, la gestione domiciliare - Competenza specialistica nelle patologie pneumologiche pure 244
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 240
The multiple components of COPD 237
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 234
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice 234
Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. 231
Genetic influences on Asthma Severity. 229
Triple therapy for symptomatic patients with COPD 229
Copd, pulmonary fibrosis and ilas in aging smokers: The paradox of striking different responses to the major risk factors 228
Chronic Obstructive Pulmonary Disease is just one component of the complex multimorbidities in patients with COPD. 227
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. 226
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. 226
What is the origin of dyspnoea in smokers without airway disease ? 222
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 220
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. 214
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials 214
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. 212
Pathology of COPD and asthma 209
Identifying and Treating COPD in Cardiac Patients 207
Reply: look at the moon, not just at the finger indicating the moon 205
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet. 203
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 202
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. 201
Asthma 200
Trattamento farmacologico dell’asma bronchiale 199
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 199
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 198
Update in Asthma 2016 196
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) 196
Cardiac Diseases and respiratory consequences 193
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation 191
Blood eosinophils for the management of COPD patients? 191
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema 190
Airway inflammation in severe chronic obstructive pulmonary disease - Relationship with lung function and radiologic emphysema 184
COPD in the elderly is almost invariably associated with one or more chronic comorbidities 183
Trattamento farmacologico dell’asma bronchiale. 177
La broncopneumopatia cronica ostruttiva 176
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 176
Subclinical cardiac dysfunction in moderate to severe COPD patients 174
Symptomatic elderly patients. The urgent need for comprehensive assessment and management 174
Totale 27.903
Categoria #
all - tutte 154.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.185


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 0 142
2021/20222.918 100 297 234 234 95 132 169 157 341 262 562 335
2022/20232.487 256 256 133 224 288 357 83 276 345 64 107 98
2023/20242.004 83 140 115 265 356 207 130 215 87 92 117 197
2024/20256.247 227 176 100 410 1.111 940 290 268 717 346 681 981
2025/202611.909 634 463 881 1.607 2.465 830 1.380 487 941 910 782 529
Totale 35.682